LSS 2024 Royalty Rate Survey

2024 Survey Highlights:

• 149 total responses were considered complete for analysis and incorporated into this report. 
• Survey respondents represented 7 of the 31 Licensing Executive Society International (LESI) Societies. 
• Respondents based on number of Deals used in the analysis: 44% Not-for-Profit, 27% Operating Companies, Organizations, 3% Government, and 27% Other.  Of the Operating companies, 68% were Biotech and 20% were Pharmaceutical.  For Not-for-Profit Organizations, 72% were academic and 23% were hospital.
  
• Respondent by Organization Composition: 23% Pharmaceutical Companies (includes Diagnostic and Drug Delivery), 73% Biotech Companies (includes Device), 5% Other.

As a convenient summary (but not a replacement of your agreement to the full Terms of Use, the Terms of Use restrict sharing and public use of the LES Royalty Rate Survey; however, the Terms of Use also authorize sharing and public use according to a set of fees (“Fee Schedule”):

LES individual members: $0

Non-LES members: $795 per individual.

All who download this report must agree to the: